Asset Allocation

As of March 31, 2026.
Type % Net
Cash 3.45%
Stock 96.55%
Bond 0.00%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 19.50%
Mid 42.09%
Small 38.41%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 100.0%    % Emerging Markets: 0.00%    % Unidentified Markets: 0.00%

Americas 92.45%
92.45%
Canada 5.72%
United States 86.73%
0.00%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.41%
United Kingdom 1.84%
5.57%
Denmark 0.71%
Ireland 2.31%
Netherlands 1.18%
Switzerland 1.37%
0.00%
0.00%
Greater Asia 0.14%
Japan 0.00%
0.00%
0.14%
Singapore 0.14%
0.00%
Unidentified Region 0.00%

Stock Sector Exposure

Cyclical
24.68%
Materials
2.54%
Consumer Discretionary
14.03%
Financials
7.60%
Real Estate
0.51%
Sensitive
52.85%
Communication Services
2.88%
Energy
2.46%
Industrials
29.19%
Information Technology
18.32%
Defensive
22.02%
Consumer Staples
0.86%
Health Care
17.40%
Utilities
3.76%
Not Classified
0.45%
Non Classified Equity
0.45%
Not Classified - Non Equity
0.00%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available